Relevant BNF section: BNF 1.6.7
▼Prucalopride (Resolor – Shire Pharmaceuticals Ltd) is licensed, only in women, for symptomatic treatment of chronic constipation when laxatives fail to provide adequate relief.1 It is promoted as being “effective in helping to restore normal bowel movements and alleviating a broad range of constipation symptoms in women.” Here we review the evidence for prucalopride and consider the drug's place as a treatment for chronic constipation.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.